These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30015653)

  • 1. Survival Analysis and Interpretation of Time-to-Event Data: The Tortoise and the Hare.
    Schober P; Vetter TR
    Anesth Analg; 2018 Sep; 127(3):792-798. PubMed ID: 30015653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When do we need competing risks methods for survival analysis in nephrology?
    Noordzij M; Leffondré K; van Stralen KJ; Zoccali C; Dekker FW; Jager KJ
    Nephrol Dial Transplant; 2013 Nov; 28(11):2670-7. PubMed ID: 23975843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of methods for estimating the attributable risk in the context of survival analysis.
    Gassama M; Bénichou J; Dartois L; Thiébaut AC
    BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study.
    Zhao L; Tian L; Uno H; Solomon SD; Pfeffer MA; Schindler JS; Wei LJ
    Clin Trials; 2012 Oct; 9(5):570-7. PubMed ID: 22914867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical primer: basics of survival analysis for the cardiothoracic surgeon.
    Thuijs DJFM; Hickey GL; Osnabrugge RLJ
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):1-4. PubMed ID: 29800119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical methods for dependent competing risks.
    Moeschberger ML; Klein JP
    Lifetime Data Anal; 1995; 1(2):195-204. PubMed ID: 9385101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Practical Overview and Reporting Strategies for Statistical Analysis of Survival Studies.
    Dey T; Mukherjee A; Chakraborty S
    Chest; 2020 Jul; 158(1S):S39-S48. PubMed ID: 32658651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.
    Rauch G; Kieser M; Ulrich S; Doherty P; Rauch B; Schneider S; Riemer T; Senges J
    Eur J Prev Cardiol; 2014 Jan; 21(1):74-80. PubMed ID: 22964966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden Imputations and the Kaplan-Meier Estimator.
    Cole SR; Edwards JK; Naimi AI; Muñoz A
    Am J Epidemiol; 2020 Nov; 189(11):1408-1411. PubMed ID: 32412079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Analysis: Where, Why, What and How?
    Indrayan A; Tripathi CB
    Indian Pediatr; 2022 Jan; 59(1):74-79. PubMed ID: 34047720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical issues in the analysis of adverse events in time-to-event data.
    Allignol A; Beyersmann J; Schmoor C
    Pharm Stat; 2016 Jul; 15(4):297-305. PubMed ID: 26929180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis in public health research.
    Lee ET; Go OT
    Annu Rev Public Health; 1997; 18():105-34. PubMed ID: 9143714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biostatistics Series Module 9: Survival Analysis.
    Hazra A; Gogtay N
    Indian J Dermatol; 2017; 62(3):251-257. PubMed ID: 28584366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiparametric regression analysis of failure time data with dependent interval censoring.
    Chen CM; Shen PS
    Stat Med; 2017 Sep; 36(21):3398-3411. PubMed ID: 28585322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-parametric estimation and model checking procedures for marginal gap time distributions for recurrent events.
    Kvist K; Gerster M; Andersen PK; Kessing LV
    Stat Med; 2007 Dec; 26(30):5394-410. PubMed ID: 17994608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiparametric methods for multistate survival models in randomised trials.
    Hudson HM; Lô SN; Simes RJ; Tonkin AM; Heritier S
    Stat Med; 2014 May; 33(10):1621-45. PubMed ID: 24338893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.